Systematic AQbD Approach to UPLC Method Development for Elacestrant and Pirtobrutinib
Year: 2025
Type: article
Abstract: The evolution of pharmaceutical analysis has led to the integration of Analytical Quality by Design (AQbD). This strategic framework enhances the robustness, reliability, and regulatory compliance of analytical methods. This review focuses on the AQbD-based development and validation of a novel Ultra Performance Liquid Chromatography (UPLC) method for the simultaneous estimation of Elacestrant and Pirtobrutinib in bulk and pharmaceutical dosage forms. Elacestrant, a selective estrogen receptor degrader, and Pirtobrutinib, a nextgeneration Bruton's tyrosine kinase (BTK) inhibitor, are emerging anticancer agents requiring precise and accurate analytical methods for quality control
Author: K.Tulasi, M.Sivakumar
Language: English
Subfield: Analytical Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W6893342250
FWCI:
Cites:
Cited by:
Related to: